Amorolfin-Mepha 5%
Amorolfin-Mepha 5% is a medicine authorised by Swissmedic under authorisation number 65132. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 October 2014 and the authorisation is valid without a time limit. ATC code D01AE16 places the medicine in the group Antifungals for dermatological use.
| Authorisation number | 65132 |
|---|---|
| Name | Amorolfin-Mepha 5% |
| Full name | Amorolfin-Mepha 5%, wirkstoffhaltiger Nagellack |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | D01AE16 |
| First authorisation | 07 October 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Amorolfin-Mepha 5%, wirkstoffhaltiger Nagellack | B | 07 October 2014 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 | ml | D01AE16 | 10.09.4. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Amorolfin-Mepha 5% authorised in Switzerland?
Yes. Amorolfin-Mepha 5% is authorised by Swissmedic under authorisation number 65132, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Amorolfin-Mepha 5% have?
Amorolfin-Mepha 5% is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Amorolfin-Mepha 5%?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.